205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
14.67%
Some net income increase while AVGO is negative at -9.78%. John Neff would see a short-term edge over the struggling competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
688.00%
Some yoy increase while AVGO is negative at -33.99%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
71.52%
Operating cash flow growth above 1.5x AVGO's 7.23%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-38.34%
Both yoy lines negative, with AVGO at -44.00%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-25.13%
Negative yoy purchasing while AVGO stands at 45.71%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-9.92%
We reduce yoy sales while AVGO is 333.33%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
100.00%
We have some outflow growth while AVGO is negative at -176.92%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-87.23%
Negative yoy issuance while AVGO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
34.25%
We have some buyback growth while AVGO is negative at -107.07%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.